ProfoundBio raises $112M to support clinical-stage oncology pipeline by Charlotte Schubert on February 13, 2024April 11, 2024 at 1:41 pm ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via an antibody and deliver a toxin or other compound to… Read More